Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer

International Journal of Experimental Pathology

Volumn 84, Issue 4, 2003, Pages 173-184

  Simpson, Peter T ^a,b,c   Shoker, Balvinder S ^b   Barraclough, Roger ^b   Halliwell, Nigel ^a   Rudland, Philip S ^b   Sibson, D Ross ^a   Davies, Michael P A ^a  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Gene expression; Metastasis; neu; S100A4; Transgenic mice

Indexed keywords

CLAUDIN; COMPLEMENTARY DNA; OSTEOPONTIN; PROTEIN S 100;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; GENE EXPRESSION; HISTOPATHOLOGY; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE NEU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0242636516     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2003.00350.x     Document Type: Article

References (32)

1. ALTSCHUL S.F., GISH W., MILLER W., MYERS E.W. & LIPMAN D.J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
2. ANANDAPPA S.Y., WINSTANLEY J.H.R., LEINSTER S., GREEN B., RUDLAND P.S. & BARRACLOUGH R. (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer 69, 772-776.
3. ANDRECHEK E.R., HARDY W.R., SIEGAL P.M., RUDNICKI M.A., CARDIFF R.D. & MULLER W.J. (2000) Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc. Natl. Acad. Sci. USA 97, 3444-3449.
4. BARRACLOUGH R. (1998) Calcium-binding protein S100A4 in health and disease. Biochim. Biophys. Acta 1448, 190-199.
5. BERNARDS R. & WEINBERG R.A. (2002) A progression puzzle. Nature 418, 823.
6. BOUCHARD L., LAMARRE L., TREMBLAY P.J. & JOLICOEUR P. (1989) Stochastic appearance of mammary tumours in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57, 931-936.
7. BRONSTEIN J.M. (2000) Function of tetraspan proteins in the myelin sheath. Curr. Opin. Neurobiol. 10, 552-557.
8. CARDIFF R.D., ANVER M.R., GUSTERSON B.A. ET AL. (2000) The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19, 968-988.
9. DAVIES B.R., DAVIES M.P., GIBBS F.E.M., BARRACLOUGH R. & RUDLAND P.S. (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8, 999-1008.
10. DAVIES M.P., HARRIS S., RUDLAND P.S. & BARRACLOUGH R. (1995) Expression of the rat, S-100-related, calcium-binding protein gene, p9Ka, in transgenic mice demonstrates different patterns of expression between these two species. DNA Cell. Biol. 14, 825-832.
11. DAVIES M.P., RUDLAND P.S., ROBERTSON L., PARRY E.W., JOLICOEUR P. & BARRACLOUGH R. (1996) Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13, 1631-1637.
12. DE BRUIN A., MULLER E., WURM S. ET AL. (1999) Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. Cell Adhes. Commun. 7, 13-28.
13. DIATCHENKO L., LAU Y.F., CAMPBELL A.P. ET AL. (1996) Suppression subtractive hybridisation: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93, 6025-6030.
14. EL-RIFAI W., FRIERSON H.F., HARPER J.C., POWELL S.M. & KNUUTILA S. (2001) Expression profiling of gastric adenocarcinoma using cDNA array. Int. J. Cancer 92, 832-838.
15. HYNES N.E. & STERN D.F. (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198, 165-184.
16. KLUS G.T., ROKAEUS N., BITTNER M.L. ET AL. (2001) Downregulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int. J. Oncol. 19, 169-174.
17. LLOYD B.H., PLATT-HIGGINS A., RUDLAND P.S. & BARRACLOUGH R. (1998) Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogens 17, 465-473.
18. MAZZUCCHELLI L. (2002) Protein S100A4: Too long overlooked by pathologists? Am. J. Pathol. 160, 7-13.
19. NATIONAL CO-ORDINATING GROUP FOR BREAST SCREENING PATHOLOGY (1997) Pathology Reporting in Breast Cancer Screening, 2nd Edn. NHSBSP Publication No. 3, Sheffield, UK.
20. OATES A.J., BARRACLOUGH R. & RUDLAND P.S. (1997) The role of osteopontin in tumourigenesis and metastasis. Invasion Metastasis 17, 1-15.
21. PEGRAM M., HSU S., LEWIS G. ET AL. (1999) Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene 18, 2241-2251.
22. PEROU C.M., SORLIE T., EISEN M.B. ET AL. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752.
23. PERQUIN M., OSTER T., MAUL A., FROMENT N., UNTEREINER M. & BAGREL D. (2001) The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J. Cancer Res. Clin. Oncol. 127, 368-374.
24. PLATT-HIGGINS A.M., RENSHAW C.A., WEST C.R. ET AL. (2000) Comparison of the metastasis-inducing protein S100A4 (p9Ka) with other prognostic markers in human breast cancer. Int. J. Cancer 89, 198-208.
25. RAMASWAMY S., ROSS K.N., LANDER E.S. & GOLUB T.R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54.
26. ROSS J.S. & FLETCHER J.A. (1999) The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy. Semin. Cancer Biol. 9, 125-138.
27. ROSTY C., UEKI T., ARGANI P. ET AL. (2002) Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am. J. Pathol. 160, 45-50.
28. RUDLAND P.S., PLATT-HIGGINS A.M., RENSHAW C.A. ET AL. (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 60, 1595-1603.
29. TAKENAGA K., NAKANISHI H., WADA K. ET AL. (1997) Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin. Cancer Res. 3, 2309-2316.
30. TODD R., MCBRIDE J., TSUJI T. ET AL. (1995) Deleted in oral cancer-1 (doc-1), a novel oral tumour suppressor gene. FASEB J. 9, 1362-1370.
31. TUCK A.B., ARSENAULT D.M., O'MALLEY F.P. ET AL. (1999) Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 18, 4237-4246.
32. WINSTANLEY J., COOKE T., MURRAY G.D. ET AL. (1991) The long term prognostic significance of c-erbB-2 in primary breast cancer. Br. J. Cancer 63, 447-450.